Replies to post #104193 on Biotech Values

[jq1234]

At least all of VVUS risks were very hypothetical with no evidence.

Are you serious? Let's forget phentermine for a moment, Topiramate has long history of serious adverse events, and JNJ discontinued development for obesity.

Lorcaserin has its own problem.